Compare Humana Inc (HUM) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Tesla, Inc. — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while Tesla, Inc. trades at $332.56 (market cap $1.31T). The key difference: Tesla, Inc. is far larger — about 28.3× Humana Inc's market cap, and Humana Inc pays a 0.92% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| HUM | TSLA | |
|---|---|---|
Market Cap | $46.31B | $1.31T |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $489.88 |
52-Week Low | $163.67 | $298.16 |
Enterprise Value | $53.67B | $1.28T |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Tesla trades at $332.71, up 1.26% with mixed technical signals showing bearish moving averages but neutral oscillators. The company faces valuation concerns with a P/E of 306.37 and declining profit margins, though recent earnings beat expectations in two of the last three quarters. Regulatory approval for driver assistance software in Europe and strong German registration growth provide positive catalysts amid competitive pressures.
Tesla's outlook balances innovation potential against valuation risks. The stock offers exposure to autonomous driving leadership and energy growth, but faces margin compression, high multiples, and execution challenges. Analyst consensus targets $393.87 with 40.74% buy ratings, suggesting moderate upside potential if future growth materializes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
